Weledji E.P. “ .2024 .The Aetiology and Pathogenesis of Colorectal Cancer. Clin Oncol, 9 : 2474.
Roshandel G.,Cancers G.,January G. .2024 .Colorectal Cancer: Epidemiology, Risk Factors and Prevention. , 16(8) : .
Cao Q.,Implications Prognostic,March Prognostic .2024 .Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic. International Journal of Molecular Sciences, 25(6) : .
Ibrahem S. .2022 .Trends in Colorectal Cancer in Iraq over Two Decades: Incidence, Mortality, Topography. ” Annals of Saudi Medicine, 252(4) : 0256-4947.
Weon J.L.,Potts P.R. .2015 .. The MAGE Protein Family and Cancer.” Current Opinion in Cell Biology, 08 : 1-8.
Khalvandi A. . .Nuclear Overexpression Levels of MAGE-A3 Predict Poor Prognosis in Patients with Prostate Cancer. ” APMIS, 129(6) : 291-303.
Su J.,April J. .2025 .Unveiling MAGEA3: A Novel Predictive Biomarker for Bevacizumab Resistance in Colorectal Cancer. Cancer Drug Resistance, 35 : .
Alves P.M.S. . .Molecular and Immunological Evaluation of the Expression of Cancer/Testis Gene Products in Human Colorectal Cancer. Cancer Immunology, Immunotherapy, 56(6) : 839-847.
Pineda C.T. .2015 .Degradation of AMPK by a CancerSpecific Ubiquitin Ligase. ” Cell, 01(4) : 715-728.
Szincsak S.,Meta-Analysis S. .2025 .Predicting Immunotherapy Efficacy with Machine Learning in Gastrointestinal Cancers: A Systematic Review. International Journal of Molecular Sciences, 26(13) : .
Livak T.D.,Schmittgen T.D.,Method ΔΔCT .2001 .Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2. ” Methods, 1262(2001) : 402-408.
Vafaei S. .2019 .Common Molecular Markers between Circulating Tumor Cells and Blood Exosomes in Colorectal Cancer: A Systematic and Analytical Review. Cancer Management and Research, 11 : 8669-8698.
Shin K.C. .2011 .MAGE A1-A6 RT-PCR and MAGE A3 and p16 Methylation Analysis in Induced Sputum from Patients with Lung Cancer and Non-Malignant Lung Diseases. Oncology Reports, 1566(2012) : 911-916.
Ries J. .2012 .Grade of Dysplasia for Predicting Malignant Progression of Oral Leukoplakia. International Journal of Oncology, 1532(2012) : 1085-1093.
Bhutani M. .2010 .Frequent Expression of MAGE1 Tumor Antigens in Bronchial Epithelium of Smokers without Lung Cancer.” Experimental and Therapeutic Medicine. , 176(2010) : 137-142.
Hudolin T. . .Immunohistochemical Expression of Tumor Antigens MAGE-A1, MAGE-A3/4 and NY-ESO-1 in Cancerous and Benign Prostatic Tissue. ” Prostate, 66(2006) : 13-18.
Kumara Shantha,H.M.C. Shantha .12 .MAGE-A3 Is Highly Expressed in a Subset of Colorectal Cancer Patients. ” Cancer Immunology, 16 : 1424-9634.
Mori M. . .Expression of MAGE Genes in Human Colorectal Carcinoma. ” Annals of Surgery, 224(1996) : 8000-00011.
Gonzalez R.,PD-L1 Protein Show Bladder,Cancer Bladder .2024 .Abstract 2513: MAGE-A3, MAGE-A4 and. 6 Suppl, 2513 : AM2024-7445.
Koyanagi K. .2008 .Prognostic Relevance of Occult Nodal Micrometastases and Circulating Tumor Cells in Colorectal Cancer in a Prospective Multicenter Trial. ” Clinical Cancer Research, 08(22) : 1078-0432.
Batchu R.B. .2009 .B Cell Transduction of Capsid Mutant (Y730F) Adeno-Associated Virus-2 Vectors with MAGE-A3 Gene for Immunotherapy of Colorectal Cancer. , 11 : .
Almutairi M.H. .2022 .Identification of MAGE-A Family Genes in Colon Cancer Patients and Their Expression Mechanism. ” Journal of King, 102251(7) : .
Han A .2024 .Abstract 2746: MAGE-A3 Co-Expression with IDH1-R132H and IL-1β in Colon Cancer. 6 Suppl, 2746 : AM2024-7445.